78 related articles for article (PubMed ID: 6244009)
1. Anomalous behavioral response to imidazoleacetic acid, a GABA agonist, in animals treated chronically with haloperidol.
Freed WJ; Gillin JC; Wyatt RJ
Biol Psychiatry; 1980 Feb; 15(1):21-35. PubMed ID: 6244009
[TBL] [Abstract][Full Text] [Related]
2. Haloperidol (but not ziprasidone) withdrawal enhances cocaine-induced locomotor activation and conditioned place preference in mice.
Fukushiro DF; Alvarez Jdo N; Tatsu JA; de Castro JP; Chinen CC; Frussa-Filho R
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):867-72. PubMed ID: 17368685
[TBL] [Abstract][Full Text] [Related]
3. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
[TBL] [Abstract][Full Text] [Related]
4. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
[TBL] [Abstract][Full Text] [Related]
5. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
[TBL] [Abstract][Full Text] [Related]
6. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
[TBL] [Abstract][Full Text] [Related]
7. Haloperidol (but not ziprasidone) withdrawal potentiates sensitization to the hyperlocomotor effect of cocaine in mice.
Fukushiro DF; Carvalho Rde C; Ricardo VP; Alvarez Jdo N; Ribeiro LT; Frussa-Filho R
Brain Res Bull; 2008 Sep; 77(2-3):124-8. PubMed ID: 18721669
[TBL] [Abstract][Full Text] [Related]
8. [Participation of GABA-ergic structures in producing the effects of haloperidol].
Ostrovskaia RU; Molodavkin GM
Biull Eksp Biol Med; 1980 Mar; 89(3):313-5. PubMed ID: 6248144
[TBL] [Abstract][Full Text] [Related]
9. Effect of 5-HT1B/D receptor agonist and antagonist administration on motor function in haloperidol and MPTP-treated common marmosets.
Jackson MJ; Al-Barghouthy G; Pearce RK; Smith L; Hagan JJ; Jenner P
Pharmacol Biochem Behav; 2004 Nov; 79(3):391-400. PubMed ID: 15582011
[TBL] [Abstract][Full Text] [Related]
10. The motor-impairing effects of GABA(A) and GABA(B) agonists in gamma-hydroxybutyrate (GHB)-treated rats: cross-tolerance to baclofen but not flunitrazepam.
Smith MA; Gergans SR; Lyle MA
Eur J Pharmacol; 2006 Dec; 552(1-3):83-9. PubMed ID: 17026996
[TBL] [Abstract][Full Text] [Related]
11. Behavioral supersensitivity to methamphetamine following chronic treatment with (--)-sulpiride in the rat.
Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
Boll Soc Ital Biol Sper; 1981 Feb; 57(4):401-6. PubMed ID: 7195265
[TBL] [Abstract][Full Text] [Related]
12. Regulation of gamma-aminobutyric acid metabolism in different brain structures by cholinergic and adrenergic drugs.
Balakleevsky AI; Bobrova NP; Shevtchenko NV
Ann Ist Super Sanita; 1978; 14(1):133-8. PubMed ID: 756168
[TBL] [Abstract][Full Text] [Related]
13. The influence of haloperidol and propranolol on behavior and biochemical changes in the brain of mice treated with LSD.
Kocur J; Jurkowski A; Kedziora J
Pol J Pharmacol Pharm; 1977; 29(3):281-8. PubMed ID: 196269
[TBL] [Abstract][Full Text] [Related]
14. [Nonuniform effect of prolonged haloperidol administration on the GABA(A) and benzodiazepine receptors in different parts of the brain].
Vasar EE; Nurk AM; Maĭmets MO; Soosaar AKh; Allikmets LKh
Biull Eksp Biol Med; 1986 Apr; 101(4):433-6. PubMed ID: 3008878
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Fundam Clin Pharmacol; 2007 Oct; 21(5):521-9. PubMed ID: 17868205
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of adenosine reuptake inhibitors in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Pharmacology; 2007; 79(3):171-83. PubMed ID: 17377417
[TBL] [Abstract][Full Text] [Related]
17. Impaired synaptogenesis and long-term modulation of behavior following postnatal elevation of GABA levels in mice.
Levav T; Wirthaim O; Weiss R; Grossman Y; Golan H
Neuropharmacology; 2008 Feb; 54(2):387-98. PubMed ID: 18063001
[TBL] [Abstract][Full Text] [Related]
18. The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex.
Vincent SL; Adamec E; Sorensen I; Benes FM
Synapse; 1994 May; 17(1):26-35. PubMed ID: 8042144
[TBL] [Abstract][Full Text] [Related]
19. Effects of 5-hydroxytryptamine2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine.
O'Neill MF; Hicks CA; Shaw G; Parameswaran T; Cardwell GP; O'Neill MJ
J Pharmacol Exp Ther; 1998 Dec; 287(3):839-46. PubMed ID: 9864262
[TBL] [Abstract][Full Text] [Related]
20. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
Haleem DJ; Samad N; Haleem MA
Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
